NCT01434212 - Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Hepatitis

Interventions

DRUG

Interferon Alfa-2b, Ribavirin

"Interferon:dosage,5 million units/person;frequency,every other day (qod);duration,48 weeks;Subcutaneous injection.~Ribavirin: dosage,15mg/kg/day;frequency,three times a day (t.i.d);duration,48 weeks;take orally."

Trial Locations (1)

130061

First Hospital Jilin University, Changchun